Fig. 3From: Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trialPrimary endpoints. a Rate pressure product at 0.1Â mV ST-segment depression ETT-1 placebo vs. ETT-3 1.2Â mg liraglutide. b Rate pressure product at 0.1Â mV ST-segment depression ETT-2 placebo vs. ETT-4 1.8Â mg liraglutide. c ST-segment depression at peak exercise ETT-1 placebo vs. ETT-3 1.2Â mg liraglutide. d ST-segment depression at peak exercise ETT-2 placebo vs. ETT-4 1.8Â mg liraglutideBack to article page